| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash provided by financing activities | 66,142 | 36,525 |
| Net change in cash, cash equivalents and restricted cash | -5,144 | 6,092 |
| Cash and cash equivalents at beginning of period | 14,006 | - |
| Cash and cash equivalents at end of period | 8,862 | - |
aTYR PHARMA INC (ATYR)
aTYR PHARMA INC (ATYR)